All results

113 results for impact

• HEAL-IST

  Inappropriate Sinus Tachycardia (IST) is a prevalent and debilitating condition in otherwise healthy younger patients, resulting in significant loss of quality…

  Ages

  18 Years - 75 Years

  Sexes

  All

• L. johnsonii in adult with T1D

  While genetics demonstrated a major risk factor for the development of type 1 diabetes (T1D), microbiota dysbiosis has been suggested as an elicitor in…

  Ages

  18 Years - 45 Years

  Sexes

  All

• EN20-01

  The primary objective of this study is to evaluate the safety and efficacy of CNTX-6970 for the treatment of pain related to OA of the knee compared to…

  Ages

  40 Years - 90 Years

  Sexes

  All

• ADOPT PGx

  This study is comprised of three separate pharmacogenetic trials grouped into a single protocol due to similarities in the intervention, the hypotheses, and…

  Ages

  8 Years - N/A

  Sexes

  All

• Microfluidics

  Sepsis has its greatest impact in the prematurely born (preterm) population. Neonatal sepsis (sepsis within the first month of life) causes over one million…

  Ages

  23 Weeks - 42 Weeks

  Sexes

  All

• Biopsychosocial Influence on Shoulder Pain

  Chronic shoulder pain is a common, costly, and disabling problem for society. The identification of factors predictive of the development of chronic shoulder…

  Ages

  18 Years - 64 Years

  Sexes

  All

• mFOLFIRINOX vs. FOLFOX With Nivolumab for First-Line Tx of Metastatic HER2- GE Adendocarcinoma

  This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil,…

  Ages

  18 Years - N/A

  Sexes

  All

• Walking and mobility decline in older adults (Mind in Motion)

  The objective of this study is to determine the central neural control of mobility in older adults by acquiring data with multiple modalities of neuroimaging…

  Ages

  20 Years - 110 Years

  Sexes

  All

• IMPACT; Phase I Study of IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult GBM

  This is a phase I study to assess the safety and feasibility of IL-8 receptor modified patient-derived activated CD70 CAR T cell therapy in CD70+ adult…

  Ages

  18 Years - 80 Years

  Sexes

  All

• Vasomune AV001-004

  A Phase 2a, randomized, double-blind, placebo-controlled, multiple ascending dose study in patients who are hospitalized with presumed pneumonia requiring…

  Ages

  18 Years - N/A

  Sexes

  All